$2.15
0.094.37%
At Close: -
$2.15
00.00%
After Hours: Jul 3, 9:26 AM EDT
15 minutes delayed
Innate Pharma
IPHANASDAQ
Innate Pharma (NASDAQ:IPHA) Stock, Earnings Estimates, EPS, And Revenue
Innate Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 21
EPS
$-0.100
Quarterly Revenue
$66.3M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$51.9M
Analyze the earnings history of Innate Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPHA | Innate Pharma | $0.02 | — | — | — | $43.48M | — | — | — | 09/12/2024 | Get Alert |
| IPHA | Innate Pharma | -$0.75 | — | -$0.10 | — | $58.87M | — | $66.35M | — | 03/21/2024 | Get Alert |
| IPHA | Innate Pharma | $0.09 | — | $0.02 | — | $49.88M | — | $43.48M | — | 09/14/2023 | Get Alert |
| IPHA | Innate Pharma | -$0.65 | — | -$0.75 | — | $28.25M | — | $58.87M | — | 03/23/2023 | Get Alert |
| IPHA | Innate Pharma | -$0.36 | — | $0.09 | — | $18.91M | — | $49.88M | — | 09/15/2022 | Get Alert |
| IPHA | Innate Pharma | — | — | -$0.65 | — | — | — | $28.25M | — | 03/24/2022 | Get Alert |
| IPHA | Innate Pharma | — | — | -$0.36 | — | — | — | $18.91M | — | 09/15/2021 | Get Alert |
Innate Pharma (IPHA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Innate Pharma (IPHA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Innate Pharma (NASDAQ:IPHA) reporting earnings?
Innate Pharma (IPHA) is scheduled to report earnings on September 12, 2024. The last reported earnings were for reported on March 21, 2024 for FY.
What were the latest earnings per share (EPS) for Innate Pharma (NASDAQ:IPHA)?
The Actual EPS was $-0.10, which missed the estimate of $0.00.
What were Innate Pharma’s (NASDAQ:IPHA) revenues?
The Actual Revenue was $66.3M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.